Chromosome 13-linked breast cancer susceptibility gene
CA 2239733 C · Owner: Kamb, Alexander · Inventors: Weber, Barbara L.; Simard, Jacques; Kamb, Alexander
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human breast cancer predisposing gene (BRCA2) some , mutant alleles of which cause susceptibility to cancer in particular breast , cancer. More specifically the invention relates to germline mutations in the BRCA2 gene and their use in the diagnosis of predisposition to breast cancer. The present invention further relates to somatic mutations in the BRCA2 gene in human breast cancer and their use in the diagnosis and prognosis of human breast cancer. Additionally, the invention relates to somatic mutations in the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 17, 1996 and granted April 3, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 17, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 17, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.